Abstract
A biological marker of ethanol consumption would be a valuable tool in the diagnosis and treatment of alcohol-ism. There are several areas of potential clinical applica-tion. First, a biological marker would be useful for the early detection of alcoholism, as many patients do not seek medical attention at an early stage (Clark, 1981). Previous studies have demonstrated the medical and social advantages of early intervention in the treatment of alcoholism (Reiff, 1985; Paredes, 1985). In addition, a biological marker would improve the monitoring of sobriety in alcoholics undergoing treatment. Furthermore, many patients who are suffering from a disease in which alcoholism is the suspected etiological agent (e.g., chronic pancreatitis, cirrhosis) fail to give an accurate history of their alcohol consumption. These patients are then subjected to an exhaustive diagnostic workup to rule out other etiological factors. A reliable biological marker of alcoholism would expedite the diagnostic workup and perhaps avoid invasive procedures (e.g., endoscopic retrograde pancreatography, liver biopsy). Finally, selected patients with alcohol-induced liver disease may become candidates for liver transplantation if there is a proven record of abstinence (Maddrey and Van Thiel, 1988); a reliable biological marker would provide objective verification of absti-nence and thus improve the selection process.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adachi, J., Mizoi, Y., Fukunaga, T., Ueno, Y., Imamichi, H., Ninomiya, I., and Naito, T.: Individual difference in urinary excretion of salsolinol in alcoholic patients. Alcohol 3:371–375,1986.
Adair, W. L., and Keller, R. K.: Dolichol metabolism in rat liver. Determination of the subcellular distribution of dolichyl phosphate and its site and rate of de novo biosynthesis. J. Biol. Chem. 257:8990–8996, 1982.
Agarwal, D. P., Tobar-Rojas, L., Harada, S., and Goedde, H. W.: Comparative study of erythrocyte aldehyde dehydrogenase in alcoholics and control subjects. Pharmacol. Biochem. Behay. 18:(Suppl. 1):89–95, 1983a.
Agarwal, D. P., Philippu, G., Milech, U., Ziemsen, B., Schrappe, O., and Goedde, H. W.: Platelet monoamine oxidase and erythrocyte catechol-O-methyltransferase activity in alcohol-ism and controlled abstinence. Drug Alcohol Depend. 12:85– 91, 1983b.
Alexopoulos, G. S., Lieberman, K. W, and Frances, R. J.: Platelet MAO activity in alcoholic patients and their first-degree relatives. Am. J. Psychiatry 140:1501–1504, 1983.
Ailing, C., Gustaysson, L., and Änggard, E.: An abnormal phos-pholipid in rat organs after ethanol treatment. FEBS Lett. 152:24–28, 1983.
Ailing, C., Gustaysson, L., Mansson, J. E., Benthin, G., and Änggard, E.: Phosphatidylethanol formation in rat organs after ethanol treatment. Biochim. Biophys. Acta 793:119–122, 1984.
American Psychiatry Association: Diagnostic and Statistical Man-ual of Mental Disorders (3rd ed., rev.). Washington, APA, 1987, pp. 165–185.
Azizi, F.: y-Glutamyl transpeptidase levels in thyroid disease. Arch. Intern. Med. 142:79–81, 1982.
Bagrel, A., d’Houtaud, A., Gueguen, R., and Siest, G.: Relations between reported alcohol consumption and certain biological variables in an “unselected” population. Clin. Chem. 25: 1242–1246,1979.
Baraona, E., Di Padova, C., Tabasco, J., and Lieber, C. S.: Red blood cells: A new major modality for acetaldehyde transport from liver to other tissues. Life Sci. 40:253–258, 1987.
Barboriak, J. J., Jacobson, G. R., Cushman, P., Herrington, R. E., Lipo, R. E, Daley, M. E., and Anderson, A. J.: Chronic alcohol abuse and high density lipoprotein cholesterol. Alco-holism: Clin. Exp. Res. 4:346–349, 1980.
Barboriak, J. J., Alaupovic, P., and Cushman, P.: Abstinence-induced changes in plasma apolipoprotein levels of alco-holics. Drug Alcohol Depend. 8:337–343, 1981.
Barrison, I. G., Viola, L., and Murray-Lyon, I. M.: Do housemen take an adequate drinking history? Br. Med. J. 281:10–40, 1980.
Barrison, I. G., Ruzek, J., and Murray-Lyon, I. M.: Drink-watchers—description of subjects and evaluation of labora-tory markers of heavy drinking. Alcohol Alcoholism 22:147–154, 1987.
Baxter, S., Fink, R., Leader, A. R., and Rosalki, S. B.: Laboratory tests for excessive alcohol consumption evaluated in general practice. Br. J. Alcohol Alcoholism 15:164–166, 1980.
Beck, O., Bosin, T. R., Lundman, A., and Borg, S.: Identification and measurement of 6-hydroxy-l-methyl-1,2,3,4-tetrahy-dro-13-carboline by gas chromatography–mass spectrometry. Biochem. Pharmacol. 31:2517–2521, 1982.
Behrens, U. J., Worner, T. M., and Lieber, C. S.: Changes in carbohydrate-deficient transferrin levels after alcohol with-drawal. Alcoholism: Clin. Exp. Res. 12:539–544, 1988a.
Behrens, U. J., Worner, T. M., Braly, L. F., Schaffner, F., and Lieber, C. S.: Carbohydrate-deficient transferrin, a marker for chronic alcohol consumption in different ethnic popula-tions. Alcoholism: Clin. Exp. Res. 12:427–432, 1988b.
Behrens, U. J., Hoerner, M., Lasker, J. M., and Lieber, C. S.: Formation of acetaldehyde adducts with ethanol-inducible P4501IE1 in vivo. Biochem. Biophys. Res. Commun. 154: 584–590, 1988c.
Behrens, U. J., Ma, X. L., Bychenok, S., Baraona, E., and Lieber, C. S.: Acetaldehyde–collagen adducts in CCl4-induced liver injury in rats. Biochem. Biophys. Res. Commun. 173:111–119, 1990.
Belfrage, P., Berg, B., Cronholm, T., Elmqvist, D., Hagerstrand, I., Johansson, B., Nilsson-Ehle, P., Norden, G., Sjovall, J., and Wiebe, T.: Prolonged administration of ethanol to young, healthy volunteers: Effects on biochemical, morphological and neurophysiological parameters. Acta Med. Scand. [ Suppl ;]. 552:1–44, 1973.
Belfrage, P., Berg, B., Hagerstrand, I., Nilsson-Ehle, P., Tornqvist, H., and Wiebe, T.: Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur. J. Clin. Invest. 7:127–131, 1977.
Bell, H.; Stromme, J. H., Steensland, H., and Bache-Wiig, J. E.: Plasma HDL-cholesterol and estimated ethanol consumption in 104 patients with alcohol dependence syndrome. Alcohol Alcoholism 20:35–40, 1985.
Bernadt, M. W., Mumford, J., Taylor, C., Smith, B., and Murray, R. M.: Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet 1:325–328, 1982.
Bertiere, M. C., Betoulle, D., Apfelbaum, M., and Girard-Globa, A.: Time-course, magnitude and nature of the changes in-duced in HDL by moderate alcohol intake in young non-drinking males. Atherosclerosis 61:7–14, 1986.
Bilai, A. M., Kristof, J., and El-Islam, M. F.: A cross-cultural application of a drinking behaviour questionnaire. Addict. Behav. 12:95–101, 1987.
Bliding, G., Bliding, A., Fex, G., and Tornqvist, C.: The appro-priateness of laboratory tests in tracing young heavy drinkers. Drug Alcohol Depend. 10:153–158, 1982.
Blum, K., Noble, E.P., Sheridan, P.J., Montgomery, A., Ritchie, T, Jagadeeswaran, P., Nogami, H., Briggs, A. H., and Cohn, J. B.: Allelic association of human dopamine D2 receptor gene in alcoholism. J.A.M.A. 263:2055–2060, 1990.
Bolos, A. M., Dean, M., Lucas-Derse, S., Ramsburg, M., Brown, G. L., and Goldman, D.: Population and pedigree studies reveal a lack of association between the dopamine D 2 receptor gene and alcoholism. J.A.M.A. 264:3156–3160, 1990.
Brown, G. W.: Discriminant analysis. Am. J. Dis. Child. 138:395–400, 1984.
Burr, M. L., Fehily, A. M., Butland, B. K., Bolton, C. H., and Eastham, R. D.: Alcohol and high-density-lipoprotein cho-lesterol: A randomized controlled trial. Br. J. Nutr. 56:81–86, 1986.
Bush, B., Shaw, S., Cleary, P., Delbanco, T. L., and Aronson, M. D.: Screening for alcohol abuse using the CAGE question-naire. Am. J. Med. 82:231–235, 1987.
Camargo, C. A., Williams, P. T., Vranizan, K. M., Albers, J. J., and Wood, P. D.: The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II: A controlled study. J.A.M.A. 253:2854–2857, 1985.
Carney, M. W. P., and Sheffield, B.: Serum folate and B12 and haematological status of in-patient alcoholics. Br. J. Addict. 73:3–7, 1978.
Carroll, R. B.: Analysis of alcohol beverages by gas–liquid chromatography. Q. J. Stud. Alcohol (Suppl. 5):6–19, 1970.
Chalmers, D. M., Levi, A. J., Chanarin, I., North, W. R. S., and Meade, T. W: Mean cell volume in a working population: The effects of age, smoking, alcohol and oral contraception. Br. J. Haematol. 43:631–636, 1979.
Chalmers, D. M., Rinsler, M. G., MacDermott, S., Spicer, C. C., and Levi, A. J.: Biochemical and haematological indicators of excessive alcohol consumption. Gut 22:992–996, 1981.
Chan, A. W. K., Welte, J. W., and Whitney, R. B.: Identification of alcoholism in young adults by blood chemistries. Alcohol 4:175–179, 1987.
Cheung, M. C., and Albers, J. J.: The measurement of apolipopro-tein A-I and A-II levels in men and women by immunoassay. J. Clin. Invest. 60:43–50, 1977.
Chick, J., Kreitman, N., and Plant, M.: Mean cell volume and gamma-glutamyl-transpeptidase as markers of drinking in working men. Lancet 1:1249–1251, 1981.
Chick, J., Longstaff, M., Kreitman, N., Plant, M., Thatcher, D., and Waite, J.: Plasma α-amino-n-butyric acid : leucine ratio and alcohol consumption in working men and in alcoholics. J. Stud. Alcohol 43:583–587, 1982.
Chojnacki, T., and Daliner, G.: The biological role of dolichol. Biochem. J. 251:1–9, 1988.
Clark, P. M. S., Kricka, L. J., and Zaman, S.: Drivers, binge drinking, and gamma-glutamyltranspeptidase. Br. Med. J. 285:1656–1657, 1982.
Clark, P. M. S., Holder, R., Mullet, M., and Whitehead, T. P.: Sensitivity and specificity of laboratory tests for alcohol abuse. Alcohol Alcoholism 18:261–269, 1983.
Clark, W. D.: Alcoholism: Blocks to diagnosis and treatment. Am. J. Med. 71:275–286, 1981.
Clermont, R. J., and Chalmers, T. C.: The transaminase tests in liver disease. Medicine 46:197–207, 1967.
Cloninger, C. R.: Neurogenetic adaptive mechanisms in alcohol-ism. Science 236:410–416, 1980.
Cohen, J. A., and Kaplan, M. M.: The SGOT/SGPT ratio—an indicator of alcoholic liver disease. Dig. Dis. Sci. 24:835–838, 1979.
Collins, M. A.: Acetaldehyde and its condensation products as markers in alcoholism. Recent Dev. Alcohol 6:387–403, 1988.
Collins, M. A., Num, W. P., Borge, G. F., Teas, G., and Goldfarb, C.: Dopamine-related tetrahydroisoquinolines: Significant urinary excretion by alcoholics after alcohol consumption. Science 206:1184–1186, 1979.
Correia, J. P., Alves, P. S., and Camilo, E. A.: SGOT-SGPT ratios. Dig. Dis. Sci. 26:284, 1981.
Crabb, D. W.: Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption. J. Clin. Invest. 85:311–315, 1990.
Crouse, J. R., and Grundy, S. M.: Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J. Lipid Res. 25:486–496, 1984.
Curry, M. D., Alaupovic, P., and Suenram, C. A.: Determination of apolipoprotein A and its constitutive A-I and A-II polypep-tides by separate electroimmunoassays. Clin. Chem. 22:315–322,1976.
Cushman, P., Barboriak, J. J., Liao, A., and Hoffman, N. E.: Association between plasma high density lipoprotein choles-terol and antipyrine metabolism in alcoholics. Life Sci. 30 :1721–1724,1982.
Cushman, P, Jacobson, G., Barboriak, J. J., and Anderson, A. J.: Biochemical markers for alcoholism: Sensitivity problems. Alcoholism: Clin. Exp. Res. 8:253–257, 1984.
Dai, W.S., LaPorte, R.E., Hom, D.L., Kuller, L.H., D’Antonio, J. A., Gutai, J. P., Wozniczak, M., and Wohlfahrt, B.: Alcohol consumption and high density lipoprotein choles-terol concentration among alcoholics. Am.J. Epidemiol. 122: 620–627, 1985.
Danielsson, B., Ekman, R., Fex, G., Johansson, B. G., Kristensson, H., Nilsson-Ehle, P., and Wadstein, J.: Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand. J. Clin. Lab. Invest. 38:113–119,1978.
Davidson, R. J. L., and Hamilton, P. J.: High mean red cell volume: Its incidence and significance in routine haematol-ogy. J. Clin. Pathol. 31:493–498, 1978.
Davis, L. J., Hurt, R. D., Morse, R. M., and O’Brien, P. C.: Discriminant analysis of Self-Administered Alcoholism Screening Test. Alcoholism: Clin. Exp. Res. 11:269–273, 1987.
Desai, K., Owen, J. S., Wilson, D. T., and Hutton, R. A.: Platelet aggregation and plasma lipoproteins in alcoholics during alcohol withdrawal. Thromb. Haemostas. 55:173–177, 1986.
Devenyi, P, Robinson, G. M., Kapur, B. M., and Roncari, D. A. K.: High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease. Am. J. Med. 71:589–594, 1981.
Devgun, M. S., Dunbar, J. A., Hagart, J., Martin, B. T., and Ogston, S. A.: Effects of acute and varying amounts of alcohol consumption on alkaline phosphatase, aspartate transaminase, and y-glutamyltransferase. Alcoholism: Clin. Exp. Res. 9:235–237, 1985.
Devor, E. J., Reich, T., and Cloninger, C. R.: Genetics of alcohol-ism and related end-organ damage. Semin. Liver Dis. 8:1–11, 1988.
Diamond, I., Wrubel, B., Estrin, W., and Gordon, A.: Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients. Proc. Natl. Acad. Sci. U.S.A. 84:1413–1416, 1987.
Diehl, A. M., Potter, J., Boitnott, J., Van Duyn, M. A., Herlong, H. F., and Mezey, E.: Relationship between pyridoxal 5 ’-phosphate deficiency and aminotransferase levels in alco-holic hepatitis. Gastroenterology 86:632–636, 1984.
Dienstag, J. L., Carter, E. A., Wands, J. R., Isselbacher, K. J., and Fischer, J. E.: Plasma α-amino-n-butyric acid to leucine ratio: Nonspecificity as a marker for alcoholism. Gastroenterology 75:561–565, 1978.
DiPadova, C., Worner, T. M., and Lieber, C. S.: Effect of absti-nence on the blood acetaldehyde response to a test dose of alcohol in alcoholics. Alcoholism: Clin. Exp. Res. 11:559–561,1987.
Dolinsky, Z. S., and Schnitt, J. M.: Discriminant function analysis of clinical laboratory data. Use in alcohol research. Recent Dev. Alcohol 6:367–385, 1988.
Dolinsky, Z. S., Shaskan, E. G., and Hesselbrock, M. N.: Basic aspects of blood platelet monoamine oxidase activity in hospitalized men alcoholics. J. Stud. Alcohol 46:81–85, 1985.
Dreyfus, J. C., Schapira, G., and Schapiro, F.: Serum enzymes in the physiopathology of muscle. Ann. N.Y. Acad. Sci. 75:235–249,1959.
Dunbar, J. A., Hagart, J., Martin, B., Ogston, S., and Devgun, M. S.: Drivers, binge drinking, and gam-maglutamyltranspeptidase. Br. Med. J. 285:1083, 1982.
Eckardt, M. J., Ryback, R. S., Rawlings, R. R., and Graubard, B. I.: Biochemical diagnosis of alcoholism. A test of the discriminating capabilities of y-glutamyl transpeptidase and mean corpuscular volume. J.A.M.A. 246:2707–2710, 1981.
Ekman, R., Fex, G., Johansson, B. G., Nilsson-Ehle, P, and Wadstein, J.: Changes in plasma high density lipoproteins and lipolytic enzymes after long-term, heavy ethanol con-sumption. Scand. J. Clin. Lab. Invest. 41:709–715, 1981.
Ekstrom, T., Eggens, I., and Danner, G.: Biosynthesis of dolichol and dolichylphosphate in rat hepatocytes in vivo. FEBS Lett. 150:133–136, 1982.
Ellingboe, J., Mendelson, J. H., Varanelli, C. C., Neuberger, O., and Borysow, M.: Plasma alpha amino-n-butyric acid : leu-cine ratio. Normal values in alcoholics. J. Stud. Alcohol 39: 1467–1476, 1978.
Ellis, G., Goldberg, D. M., Spooner, R. J., and Ward, A. M.: Serum enzyme tests in diseases of the liver and biliary tree. Am, J. Clin. Pathol. 70: 248–258, 1978.
Elmberger, P. G., Karen, A., Appelkvist, E. L., and Dallner, G.: In vitro and in vivo synthesis of dolichol and other main mevalo-nate products in various organs of the rat. Eur. J. Biochem. 168:1–11, 1987.
Eriksen, J., Olsen, P. S., and Thomsen, A. C.: Gamma-glutamyl-transpeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consump-tion in liver disease. Scand. J. Gastroenterol. 19:813–819, 1984.
Eriksen, S. P., and Kulkarni, A. B.: Methanol in normal human breath. Science 141;639–640, 1963.
Eriksson, S., Fex, G., Johansson, B., and Nilsson, B.: Plasma alpha-amino-n-butyric acid/leucine ratio in alcoholism. N. Engl. J. Med. 300:93–94, 1979.
Eschwege, E., Papoz, L., Lellouch, J., Claude, J. R., Cubeau, J., Pequignot, G., Richard, J. L., and Schwartz, D.: Blood cells and alcohol consumption with special reference to smoking habits. J. Clin. Pathol. 31:654–658, 1978.
Faraj, B. A., Lenton, J. D., Kutner, M., Camp, V. M., Stammers, T. W., Lee, S. R., Loties, P. A., and Chandora, D.: Prevalence of low monoamine oxidase function in alcoholism. Alcohol-ism: Clin. Exp. Res. 11:464–467, 1987.
Faraj, B. A., Camp, V. M., Davis, D. C., Lenton, J. D., and Kutner, M.: Elevation of plasma salsolinol sulfate in chronic alcoholics as compared to nonalcoholics. Alcoholism: Clin. Exp. Res. 13:155–163, 1989.
Felig, P., Marliss, E., Oilman, J. L., and Cahill, G. F.: Plasma amino acid levels in diabetic ketoacidosis. Diabetes 19:727– 729,1970.
Finkelstein, J. D., Cello, J.P.j. and Kyle, W. E.: Ethanol-induced changes in methionine metabolism in rat liver. Biochem. Biophys. Res. Commun. 61;525–531, 1974.
Fishman, W. H.: Perspectives on alkaline phosphatase iso-enzymes. Am. J. Med. 56:617–650, 1974.
Fraser, G. E., Anderson, J. T., Foster, N., Goldberg, R., Jacobs, D., and Blackburn, H.: The effect of alcohol on serum high density lipoprotein (HDL). A controlled experiment. Athero-sclerosis 46:275–286, 1983.
Freedland, K. E., Frankel, M. T, and Evenson, R. C.: Biochemi-cal diagnosis of alcoholism in men psychiatry patients. J. Stud. Alcohol 46:103–106, 1985.
Fuller, R. K., Lee, K. K., and Gordis, E.: Validity of self-report in alcoholism research: Results of a Veterans Administration cooperative study. Alcoholism: Clin. Exp. Res.. 12:201–205, 1988.
Gadeholt, G., Aarbakke, J., Dybing, E., Sjoblom, M., and Morland, J.: Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet. J. Pharmacol. Exp. Ther. 213:196–203, 1980.
Garvin, R. B., Foy, D. W., and Alford, G. S.: A critical examin-ation of gamma-glutamyl transpeptidase as a biochemical marker for alcohol abuse. Addict. Behay. 6:377–383, 1981.
Giblett, E. R.: The plasma transferrins. Prog. Med. Genet. 2:34–63, 1962.
Gill, G. V., Baylis, P. H., Rear, C. T. G., Skillen, A. W., and Diggle, P. H.: Acute biochemical responses to moderate beer drinking. Br. Med. J. 285:1770–1773, 1982.
Giller, E., Nocks, J., Hall, H., Stewart, C., Schnitt, J., and Sherman, B.: Platelet and fibroblast monoamine oxidase in alcoholism. Psychiatry Res. 12:339–347, 1984.
Gjerde, H., and Morland, J.: Concentrations of carbohydrate-deficient transferrin in dialysed plasma from drunken drivers. Alcohol Alcoholism. 22:271–276, 1987.
Glueck, C. J.: Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: Therapeutic approaches to prevention of atherosclerosis. Am. Heart J. 110:1107–1115, 1985.
Glueck, C. J., Laskarzewski, P. M., Rao, D. C., and Morrison, J. A.: Familial aggregation of coronary risk factors. In: Coro-nary Artery Disease: Prevention Complication and Treat-ment, (W. E. Connor, and J. D. Bristow, eds.), Philadelphia, J.B. Lippincott, 1985. pp. 173–192.
Gluud, C., Andersen, I., Deitrichson, O., Gluud, B., Jacobsen, A., and Juhl, E.: Gamma-glutamyltransferase, aspartate ami-notransferase and alkaline phosphatase as markers of alcohol consumption in out-patient alcoholics. Eur. J. Clin. Invest. 11:171–176, 1981.
Goldberg, R. B., Karlin, J. B., Juhn, D. J., Scanu, A. M., Edelstein, C., and Rubenstein, A. H.: Characterization and measurement of human apolipoprotein A-II radioimmuno-assay. J. Lipid Res. 21:902–912, 1980.
Gordis, E., and Herschkopf, S.: Application of isoelectric focusing in immobilized pH gradients to the study of acetaldehyde-modified hemoglobin. Alcoholism: Clin. Exp. Res. 10:311–319, 1986.
Gottfried, E. L., and Wagar, E. A.: Laboratory testing: A practical guide. DM. 29:1–41, 1983.
Gottfries, C. G., Oreland, L., Wiberg, A., and Winblad, B.: Lowered monoamine oxidase activity in brains from alco-holic suicides. J. Neurochem. 25:667–673, 1975.
Hagerstrand, I.: Distribution of alkaline phosphatase activity in healthy and diseased human liver tissue. Acta. Pathol. Micro-biol. Scand. (A) 83:519–526, 1975.
Harinasuta, U., Chomet, B., Ishak, K., and Zimmerman, H. J.: Steatonecrosis—Mallory body type. Medicine 46:141–167, 1967.
Hartung, G. H., Foreyt, J. P., Mitchell, R. E., Mitchell, J. G., Reeves, R. S., and Gotto, A. M.: Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. J.A.M.A. 249:747–750, 1983.
Haskell, W. L., Camargo, C., Williams, P.T, Vranizan, K.M., Krauss, R. M., Lindgren, F.T., and Wood, P.D.: The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. N. Engl. J. Med. 310 :805–810,198
Heiss, G., Johnson, N. J., Reiland, S., Davis, C. E., and Tyroler, H. A.: The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prev-alence Study summary. Circulation 62(Suppl. IV):116–136, 1980.
Hellstrom, E., Tottmar, O., and Widerlov, E.: Effects of oral administration or implantation of disulfiram on aldehyde dehydrogenase activity in human blood. Alcoholism: Clin. Exp. Res. 7:231–236, 1983.
Hernandez-Munoz, R., Baraona, E., Blacksberg, I., and Lieber, C. S.: Characterization of the increased binding of acetalde-hyde to red blood cells in alcoholics. Alcoholism: Clin. Exp. Res. 13:654–659, 1989.
Hilderbrand, R. L., Hervig, L. K., Conway, T. L., Ward, H. W, and Markland, F. S.: Alcohol intake, ratio of plasma alpha-amino-n-butyric acid to leucine, and gamma-glutamyl trans-peptidase in nonalcoholics. J. Stud. Alcohol 40:902–905, 1979.
Hillers„ V. N., Alldredge, J. R., and Massey, L. K.: Determination of habitual alcohol intake from a panel of blood chemistries. Alcohol Alcoholism 21:199–205, 1986.
Hoberman, H. D.: Post-translational modification of hemoglobin in alcoholism. Biochem. Biophys. Res. Commun. 113:1004–-1009, 1983.
Hoberman, H. D., and Chiodo, S. M.: Elevation of the hemoglobin A1 fraction in alcoholism. Alcoholism: Clin. Exp. Res. 6:260–266, 1982.
Hoerner, M., Behrens, U. J., Worner, T. M., and Lieber, C. S.: Humoral immune response to acetaldehyde adducts in alco-holic patients. Res. Commun. Chem. Pathol. Pharmacol. 54: 3–12, 1986.
Hoerner, M., Behrens, U. J., Worner, T. M., Blacksberg, I., Braly, L. F., Schaffner, F., and Lieber, C. S.: The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 8:569–574, 1988.
Hojnacki, J. L., Cluette-Brown, J. E., Mulligan, J. J., Hagan, S. M., Mahony, K. E., Witzgall, S. K., Osmolski, T. V., and Barboriak, J. J.: Effect of ethanol dose on low density lipopro-teins and high density lipoprotein subfractions. Alcoholism: Clin. Exp. Res. 12:149–154, 1988.
Hollstedt, C., and Dahlgren, L.: Peripheral markers in the female “hidden alcoholic.” Acta Psychiatr. Scand. 75:591–596, 1987.
Homaidan, F. R., Kricka, L. J., Clark, P. M. S., Jones, S. R., and Whitehead, T. P.: Acetaldehyde—hemoglobin adducts: An unreliable marker of alcohol abuse. Clin. Chem. 30:480–482, 1984.
Hulley, S. B., and Gordon, S.: Alcohol and high-density lipopro-tein cholesterol. Causal inference from diverse study designs. Circulation 64(Suppl. M):57–63, 1981.
Hultberg, B., and Isaksson, A.: A possible explanation for the occurrence of increased ß-hexosaminidase activity in preg-nancy serum. Clin. Chim. Acta. 113:135–140, 1981.
Hultberg, B., Isaksson, A., and Tiderstrom, G.: ß-Hexos-aminidase, leucine aminopeptidase, cystidyl aminopep-tidase, hepatic enzymes and bilirubin in serum of chronic alcoholics with acute ethanol intoxication. Clin. Chim. Acta. 105:317–323, 1980.
Hultberg, B., Braconier, J. H., Isaksson, A., and Jansson, L.: 3-Hexosaminidase level in serum from patients with viral hepatitis as a measure of reticuloendothelial function. Scand. J. Infect. Dis. 13:241–245, 1981a.
Hultberg, B., Isaksson, A., and Jansson, L.: ß-Hexosaminidase in serum from patients with cirrhosis and cholestasis. Enzyme 26:296–300, 1981b.
Hultberg, B., Isaksson, A., Joelsson, B., Alwmark, A., Gull—strand,P., and Bengmark, S.: Pattern of serum beta—hexosaminidase in liver cirrhosis. Scand. J. Gastroenterol. 18:877–880, 1983.
Inoue, K., Nishimukai, H., and Yamasawa, K.: Purification and partial characterization of aldehyde dehydrogenase from hu-man erythrocytes. Biochim. Biophys. Acta. 569:117–123, 1979.
Irwin, M., Baird, S., Smith, T. L., and Schuckit, M.: Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program. Am. J. Psychiatry 145: 595–599,1988.
Isaksson, A., Blanche, C., Hultberg, B., and Joelsson, B.: Influ-ence of ethanol on the human serum level of beta-hexos-aminidase. Enzyme 33:162–166, 1985.
Ishii, H., Yasuraoka, S., Shigeta, Y., Takagi, S., Kamiya, T., Okuno, F, Miyamoto, K., and Tsuchiya, M.: Hepatic and intestinal gamma-glutamyltranspeptidase activity: Its activa-tion by chronic ethanol administration. Life Sci. 23:1393–1398, 1978.
Ishii, H., Okuno, F, Shigeta, Y., and Tsuchiya, M.: Enhanced serum glutamic oxaloacetic transaminase activity of mito-chondria) origin in chronic alcoholics. In: Currents in Alco-holism, Vol. V (M. Galanter, ed.), New York, Grune & Stratton, 1979, pp. 101–108.
Ishii, H., Ebihara, Y., Okuno, F., Munakata, Y., Takagi, T., Arai, M., Shigeta, S., and Tsuchiya, M.: y-Glutamyl transpep-tidase activity in liver of alcoholics and its histochemical loçalization. Alcoholism: Clin. Exp. Res. 10:81–85, 1986.
Israel, Y., Hurwitz, E., Niemela, O., and Arnon, R.: Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde—protein adducts. Proc. Natl. Acad. Sci. U.S.A. 83:7923–7927, 1986.
Jenkins, W. J., and Peters, T. J.: Selectively reduced hepatic acetaldehyde dehydrogenase in alcoholics. Lancet 1:628– 629, 1980.
Jones, J. D., Morse, R. M., and Hurt, R. D.: Plasma a-amino-n-butyric acid/leucine ratio in alcoholics. Alcoholism: Clin. Exp. Res. 5:363–365, 1981.
Jovanovic, L., and Peterson, C. M.: The clinical utility of glycosy-lated hemoglobin. Am. J. Med. 70:331–338, 1981.
Kaplowitz, N., Eberle, D., and Yamada, T.: Biochemical tests for liver disease. In: Hepatology: A Textbook of Liver Disease (D. Zakim and T.D. Boyer, eds.), Philadelphia, W. B. Saunders, 1982, pp. 583–612.
Karlin, J. B., Juhn, D. J., Starr, J. I., Scanu, A. M., and Rubenstein, A. H.: Measurement of human high density lipoprotein apolipoprotein A-I in serum by radioimmunoassay. J. Lipid Res. 17:30–37, 1976.
Karsenty, C., Baraona, E., Savolainen, M. J., and Lieber, C. S.: Effects of chronic ethanol intake on mobilization and excre-tion of cholesterol in baboons. J. Clin. Invest. 75:976–986, 1985.
Kopin, I. J.: Storage and metabolism of catecholamines: The role of monoamine oxidase. Pharmacol. Rev. 16:179–191, 1964.
Korri, U. M., Nuutinen, H., and Salaspuro, M.: Increased blood acetate: A new laboratory marker of alcoholism and heavy drinking. Alcoholism: Clin. Exp. Res. 9 :468–471, 1985.
Korsten, M. A., Matsuzaki, S., Feinuran, L., and Lieber, C. S.: High blood acetaldehyde levels after ethanol administration. Difference between alcoholic and nonalcoholic subjects. N. Engl. J. Med. 292 :386–389, 1975.
Kristenson, H., and Trell, E.: Indicators of alcohol consumption: Comparisons between a questionnaire (Mm-MAST), inter-views and serum y-glutamyl transferase (GGT) in a health survey of middle-aged males. Br. J. Addict. 77 :297–304, 1982.
Kristenson, H., Ohlin, H., Hulten-Nosslin, M. B., Trell, E., and Hood, B.: Identification and intervention of heavy drinking in middle-aged men: Results and follow-up of 24–60 months of long term study with randomized controls. Alcoholism: Clin. Exp. Res. 7 203–209, 1983.
Kryszewski, A. J., Neale, G., Whitfield, J. B., and Moss, D. W: Enzyme changes in experimental biliary obstruction. Clin. Chim. Acta. 47 :175–182, 1973.
Lai, C. L., Ng, R. P., and Lok, A. S. F.: The diagnostic value of the ratio of serum gamma-glutamyl transpeptidase to alkaline phosphatase in alcoholic liver disease. Scand. J. Castro-enterol. 17 :41–47, 1982.
LaPorte, R., Valvo-Gerard, L., Kuller, L., Dai, W, Bates, M., Cresanta, J., Williams, K., and Palkin, D.: The relationship between alcohol consumption, liver enzymes and high-density lipoprotein cholesterol. Circulation 64(Suppl. III):67–72, 1981.
Latcham, R. W.: Gamma glutamyl transpeptidase and mean cor-puscular volume: Their usefulness in the assessment of in-patient alcoholics. Br. J. Psychiatry 149 :353–356, 1986.
Lebsack, M. E., Gordon, E.. R., and Lieber, C. S.: Effect of chronic ethanol consumption on aldehyde dehydrogenase activity in the baboon. Biochem. Pharmacol. 30:2273–2277, 1981.
Lelbach, W K.: Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann. N.Y. Acad. Sci 252 :85–105, 1975.
Lieber, C. S.: Blood markers of alcoholic liver disease. Recent Dev. Alcoholism 6:351–365, 1988.
Lieber, C. S., DeCarli, L. M., and Rubin, E.: Sequential produc-tion of fatty liver, hepatitis and cirrhosis in sub-human pri-mates fed ethanol with adequate diets. Proc. Natl. Acad. Sci. U.S.A. 72 :437–441, 1975.
Lin, C. C., Potter, J. J., and Mezey, E.: Erythrocyte aldehyde dehydrogenase activity in alcoholism. Alcoholism: Clin. Exp. Res. 8:539–541, 1984.
Lindros, K. O., Stowell, A., Pikkarainen, P., and Salaspuro, M.: Elevated blood acetaldehyde in alcoholics with accelerated ethanol elimination. Pharmacol Biochem. Behay. 13(Suppl. 1):119–124, 1980.
Lucas, D., Menez, J. F., Bodenez, P., Baccino, E., Bardou, L. G., and Flach, H. H.: Acetaldehyde adducts with haemoglobin: Determination of acetaldehyde released from haemoglobin by acid hydrolysis. Alcohol Alcoholism 23:23–31, 1988.
Luchi, P., Curtis, G., and Bucarelli, A.: Forensic considerations on the comparison of “serum y-glutamyltranspeptidase” (“y-GT”) activity in experimental acute alcoholic intoxication and in alcoholic car drivers who caused road accidents. Foren. Sci. 11 :33–39, 1978.
Ludwig, S., and Kaplowitz, N.: Effect of pyridoxine deficiency on serum and liver transaminases in experimental liver injury in the rat. Gastroenterology 79 :545–549, 1980.
Lumeng, L., and Durant, P. J.: Regulation of the formation of stable adducts between acetaldehyde and blood proteins. Alcohol 2 :397–400, 1985.
Lumeng, L., and Li, T. K.: Vitamin B6 metabolism in chronic alcohol abuse. Pyridoxal phosphate levels in plasma and the effects of acetaldehyde on pyridoxal phosphate synthesis and degradation in human erythrocytes. J. Clin. Invest. 53:693–704,1974.
Luoma, P.V., Sotaniemi, E. A., Pelkonen, R. O., and Ehnholm, C.: High-density lipoproteins and hepatic microsomal en-zyme induction in alcohol consumers. Res. Commun. Chem. Pathol. Pharmacol. 37:91–96, 1982.
Lykouras, E., Moussas, G., and Markianos, M.: Platelet mono-amine oxidase and plasma dopamine- 3-hydroxylase activ-ities in non-abstinent chronic alcoholics. Relation to clinical parameters. Drug Alcohol Depend. 19:363–368, 1987.
Maddrey, W. C., and Van Thiel, D. H.: Liver transplantation: An overview. Hepatology 8:948–959, 1988.
Majchrowicz, E., and Mendelson, J. H.: Blood methanol concen-trations during experimentally induced ethanol intoxication in alcoholics. J. Pharmacol. Exp. Ther. 179:293–300, 1971.
Major, L. F., and Murphy, D. L.: Platelet and plasma amine oxidase activity in alcoholic individuals. Br. J. Psychiatry 132:548–554,1978.
Malmendier, C. L., Mailier, E. L., Amerijckx, J. P., and Fischer, M. L.: Plasma levels of apolipoproteins A-I, A-II and B in alcoholism: Relation to the degree of histological liver dam-age, and to liver function tests. Hepatogastroenterology 30: 236–239,1983.
Mani, J. C., Pietruszko, R., and Theorell, H.: Methanol activity of alcohol dehydrogenases from human liver, horse liver, and yeast. Arch. Biochem. Biophys. 140:52–59, 1970.
Maring, J. A., Weigand, K., Brenner, H. D., and Von Wartburg, J. P.: Aldehyde oxidizing capacity of erythrocytes in normal and alcoholic individuals. Pharmacol. Biochem. Behay. 18(Suppl. 1):135–138, 1983.
Marone, G., Plant, M., and Lichtenstein, L. M.: Characterization of a specific adenosine receptor on human lymphocytes. J. Immunol. 11:2153–2159, 1978.
Martin, J. V., Martin, P. J., and Goldberg, D. M.: Enzyme induc-tion as a possible cause of increased serum-triglycerides after oral contraceptives. Lancet 1:1107–1108, 1976.
Masarei, J. R.L., Puddey, I. B., Rouse, I. L., Lynch, W. J., Vandongen, R., and Beilin, L. J.: Effects of alcohol consump-tion on serum lipoprotein-lipid and apolipoprotein concentra-tions. Results from an intervention study in healthy subjects. Atherosclerosis 60:79–87, 1986.
Matloff, D. S., Selinger, M. J., and Kaplan, M. M.: Hepatic transaminase activity in alcoholic liver disease. Gastroenter-ology 78:1389–1392, 1980.
Matthewson, K., and Record, C. O.: Erythrocyte aldehyde dehy-drogenase activity in alcoholic subjects and its value as a marker for hepatic aldehyde dehydrogenase in subjects with and without liver disease. Clin. Sci. 70:295–299, 1986.
Mayfield, D., McLeod, G., and Hall, P: The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am. J. Psychiatry 131:1121–1123, 1974.
McNeil, B. J., Keeler, E., and Adelstein, S. J.: Primer on certain elements of medical decision making. N. Engl. J. Med. 293: 211–215, 1975.
Mezey, E., Potter, J. J., and Ammon, R. A.: Effect of ethanol administration on the activity of hepatic lysosomal enzymes. Biochem. Pharmacol. 25:2663–2667, 1976.
Mobley, R., and Huisman, T. H. J.: Minor hemoglobins (Hb A1) in chronic alcoholic patients. Hemoglobin 6:79–81, 1982.
Monteiro, M. G., Pires, M. L. N., and Masur, J.: The trauma questionnaire for detecting alcohol abuse: Limiting factors. Alcohol 3:287–289, 1986.
Moore, R. A.: The prevalence of alcoholism in a community general hospital. Am. J. Psychiatry 128:638–639, 1971.
Moore, R. A.: The diagnosis of alcoholism in a psychiatric hospital: A trial of the Michigan Alcoholism Screening Test (MAST). Am. J. Psychiatry 128:1565–1569, 1972.
Moore, R. A., and Murphy, T. C.: Denial of alcoholism as an obstacle to recovery. Q. J. Stud. Alcohol 22:597–609, 1961.
Moore, R. D., Smith, C. R., Kwiterovich, P. O., and Pearson, T. A.: Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B. Am. J. Med. 84:884–890, 1988.
Morgan, M. Y., Milson, J. P., and Sherlock, S.: Ratio of plasma alpha-amino-n-butyric acid to leucine as an empirical marker of alcoholism: Diagnostic value. Science 197:1183–1185, 1977.
Morgan, M. Y., Camilo, M. E., Luck, W., Sherlock, S., and Hoffbrand, A. V.: Macrocytosis in alcohol-related liver dis-ease: Its value for screening. Clin. Lab. Haematol. 3:35–44, 1981.
Morino, Y., Kagamiyama, H., and Wada, H.: Immunochemical distinction between glutamic—oxaloacetic transaminases from the soluble and mitochondrial fractions of mammalian tissues. J. Biol. Chem. 239:943–944, 1964.
Moussavian, S. N., Becker, R. C., Piepmeyer, J. L., Mezey, E., and Bozian, R. C.: Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease. Dig. Dis. Sci. 30:211–214, 1985.
Myrhed, M., Berglund, L., and Bottiger, L. E.: Alcohol consump-tion and hematology. Acta Med. Scand. 202:11–15, 1977.
Nagy, L. E., Diamond, I., and Gordon, A.: Cultured lymphocytes from alcoholic subjects have altered cAMP signal transduc-tion. Proc. Natl. Acad. Sci. U.S.A. 85:6973–6976, 1988.
Naito, H. K.: High-density lipoprotein (HDL) cholesterol. In: Methods in Clinical Chemistry (A. J. Pesce and L. A. Kaplan, eds.), St. Louis, C. V. Mosby, 1987a, pp. 1179–1194.
Naito, N. K.: Cholesterol. In: Methods in Clinical Chemistry (A. J. Pesce and L. A. Kaplan, eds.), St. Louis, C. V. Mosby, 1987b, pp. 1156–1178.
Nalpas, B., Vassault, A., Le Guillou, A., Lesgourgues, B., Ferry, N., Lacour, B., and Berthelot, P: Serum activity of mito-chondria’ aspartate aminotransferase: A sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology 4: 893–896,1984.
Nalpas, B., Vassault, A., Charpin, S., Lacour, B., and Berthelot, P.: Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: Diagnostic value and inter-pretation in a liver unit. Hepatology 6:608–614, 1986.
Nguyen, L. B., and Peterson, C. M.: The effect of acetaldehyde, concentrations on the relative rates of formation of acetalde-hyde-modified hemoglobins. Proc. Soc. Exp. Biol. Med. 177:226–233, 1984.
Niemela, O., Klajner, F., Orrego, H., Vidins, E., Blendis, L., and Israel, Y.: Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 7:1210–1214, 1987.
Ning, M., Baker, H., and Leevy, C. M.: Reduction of glutamic pyruvic transaminase in pyridoxine deficiency in liver dis-ease. Proc. Soc. Exp. Biol. Med. 121:27–30, 1966.
Nishimura, M., Hasumura, Y., and Takeuchi, J.: Effect of an intravenous infusion of ethanol on serum enzymes and lipids in patients with alcoholic liver disease. Gastroenterology 78 :691–695, 1980.
Nuutinen, H., Lindros, K. O., and Salaspuro, M.: Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics. Alcoholism: Clin. Exp. Res. 7:163–168, 1983.
Nuutinen, H., Lindros, K., Hekali, P, and Salaspuro, M.: Ele-vated blood acetate as indicator of fast ethanol elimination in chronic alcoholics. Alcohol 2:623–626, 1985.
Okamoto, Y., Fujimori, Y., Nakano, H., and Tsujii, T.: Role of the liver in alcohol-induced alteration of high-density lipoprotein metabolism. J. Lab. Clin. Med. 111:482–485, 1988.
Okany, C. C., Bond, A. N., and Wickramasinghe, S. N.: Effects of ethanol on cell volume and protein synthesis in a human lymphoblastoid cell line (Raji). Acta Haematol. 70:24–34, 1983.
Okuno, E., Ishii, H., Kashiwazaki, K., Takagi, S., Shigeta, Y., Arai, M., Takagi, T., Ebihara, Y., and Tsuchiya, M.: Increase in mitochondria) GOT (m-GOT) activity after chronic alco-hol consumption: Clinical and experimental observations. Alcohol 5:49–53, 1988.
Oreland, L., Wiberg, A., Asberg, M., Tlaskman, L., Sjostrand, L., Thoren, P., Bertilsson, L., and Tybring, G.: Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psy-chiatry Res. 4:21–29, 1981.
Oreland, L., Wiberg, A., Winblad, B.,Fowler, C. J., Gottfries, C. G., and Kiianmaa, K.: The activity of monoamine oxidase-A and -B in brains from chronic alcoholics. J. Neural 7}ansm. 56:73–83, 1983.
Orrego, H., Blendis, L. M., Blake, J. E., Kapur, B. M., and Israel, Y.: Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 2:1354–1356, 1979.
Orrego, H., Blake, J. E., and Israel, Y.: Relationship between gamma-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol with-drawal. Alcoholism: Clin. Exp. Res. 9:10–13, 1985.
Palmer, K. R., and Jenkins, W. J.: Impaired acetaldehyde oxidation in alcoholics. Gut 23:729–733, 1982.
Pandey, G. N., Fawcett, J., Gibbons, R., Clark, D. C., and Davis, J. M.: Platelet monoamine oxidase in alcoholism. Biol. Psy-chiatry 24:15–24, 1988.
Papoz, L, Warnet, J. M., Pequignot, G., Eschwege, E., Claude, J. R., and Schwartz, D.: Alcohol consumption in a healthy population. Relationship to y-glutamyl transferase activity and mean corpuscular volume. J.A.M.A. 245:1748–1751, 1981.
Paredes, A.: Cost effectiveness in alcoholism treatment. Subst. Abuse 6:29–37, 1985.
Peachey, J. E., and Kapur, B. M.: Monitoring drinking behavior with alcohol dipstick during treatment. Alcoholism: Clin. Exp. Res. 10:663–666, 1986.
Peele, S.: The cultural context of psychological approaches to alcoholism. Can we control the effects of alcohol? Am. Psycho. 39:1337–1351, 1984.
Pequignot, G., Tuyns, A. J., and Berta, J. L.: Ascitic cirrhosis in relation to alcohol consumption. Int. J. Epidemiol. 7:113–-120, 1978.
Persson, J., and Magnusson, P. H.: Comparison between different methods of detecting patients with excessive consumption of alcohol. Acta Med. Scand. 223:101–109, 1988.
Peterson, C. M., and Polizzi, C. M.: Improved method for acetal-dehyde in plasma and hemoglobin-associated acetaldehyde: Results in teetotalers and alcoholics reporting for treatment. Alcohol 4:477–480, 1987.
Peterson, C. M., Polizzi, C. M., and Frawley, P. J.: Artefactual increase in hemoglobins AIa+b in blood from alcoholic sub-jects. Alcoholism: Clin. Exp. Res. 10:219–220, 1986.
Peterson, C. M., Jovanovic-Peterson, L., and Schmid-Formby, F.: Rapid association of acetaldehyde with hemoglobin in human volunteers after low dose ethanol. Alcohol 5:371–374, 1988.
Petren, S., Vesterberg, O., and Jornvall, H.: Differences among five main forms of serum transferrin. Alcoholism: Clin. Exp. Res. 11:453–456, 1987.
Pikkarainen, P. H., Gordon, E. R., Lebsack, M. E., and Lieber, C. S.: Determinants of plasma free acetaldehyde levels during the oxidation of ethanol. Effects of chronic ethanol feeding. Biochem. Pharmacol. 30:799–802, 1981.
Poikolainen, K., Karkkainen, P., and Pikkarainen, J.: Correlations between biological markers and alcohol intake as measured by diary and questionnaire in men. J. Stud. Alcohol 46:383–387, 1985.
Pokorny, A. D., Miller, B. A., and Kaplan, H. B.: The brief MAST: A shortened version of the Michigan Alcoholism Screening Test. Am. J. Psychiatry 129:342–345, 1972.
Puchois, P., Fontan, M., Gentilini, J. L., Gelez, P., and Fruchart, J. C.: Serum apolipoprotein A-II, a biochemical indicator of alcohol abuse. Clin. Chim. Acta 144:185–189, 1984.
Pullarkat, R. K., and Raguthu, S.: Elevated urinary dolichol levels in chronic alcoholics. Alcoholism: Clin. Exp. Res. 9:28–30, 1985.
Rawles, J. W, Rhodes, D. L., Potter, J. J., and Mezey, E.: Characterization of human erythrocyte aldehyde dehydroge-nase. Biochem. Pharmacol. 36:3715–3722, 1987.
Reiff, S.: A cost-effectiveness study of alcoholism treatment in a health maintenance organization Subst. Abuse. 6:24–28, 1985.
Rej, R.: An immunochemical procedure for determination of mitochondrial aspartate aminotransferase in human serum. Clin. Chem. 26:1694–1700, 1980.
Roine, R. P: Effects of moderate drinking and alcohol abstinence on urinary dolichol levels. Alcohol 5:229–231, 1988.
Roine, R. P. Turpeinen, U., Ylikahri, R., and Salaspuro, M.: Urinary dolichol—a new marker of alcoholism. Alcoholism: Clin. Exp. Res. 11:525–527, 1987a.
Roine, R. P., Ylikahri, R., Koskinen, P., Suokas, A., Hamalainen, J., and Salaspuro, M.: Effect of heavy weekend drinking on urinary dolichol levels. Alcohol 4:509–511, 1987b.
Roine, R., Humaloja, K., Hamalainen, J., Nykanen, I., Ylikahri, R., and Salaspuro, M.: Significant increases in urinary dol-ichol levels in bacterial infections, malignancies and preg-nancy but not in other clinical conditions. Ann. Med. 21:13–16, 1989a.
Roine, R. P., Eriksson, C. J. P., Ylikahri, R., Penttila, A., and Salaspuro, M.: Methanol as a marker of alcohol abuse. Alcoholism: Clin. Exp. Res. 13:172–175, 1989b.
Rollason, J. G., Pincherle, G., and Robinson, D.: Serum gamma glutamyl transpeptidase in relation to alcohol consumption. Clin. Chim. Acta. 39:75–80, 1972.
Rommelspacher, H., Damm, H., Schmidt, L., and Schmidt, G.: Increased excretion of harman by alcoholics depends on events of their life history and the state of the liver. Psycho-pharmacology 87:64–68, 1985.
Rosalki, S. B., and Rau, D.: Serum y-glutamyl transpeptidase activity in alcoholism. Clin. Chim. Acta 39:41–47, 1972.
Rossouw, J. E., Labadarios, D., Davis, M., and Williams, R.: Vitamin B6 and aspartate aminotransferase activity in chronic liver disease. S. Afr. Med. J. 53:436–438, 1978.
Rowland, M., and Tozer, T. N.: Clinical Pharmacokinetics: Con-cepts and Applications. Philadelphia, Lea & Febiger, 1989, p. 385.
Rutenburg, A. M., Goldbarg, J. A., and Pineda, E. P: Serum -y-glutamyl transpeptidase activity in hepatobiliary pancre-atic disease. Gastroenterology 45:43–48, 1963.
Ryback, R. S., Eckardt, M. J., Rawlings, R. R., and Rosenthal, L. S.: Quadratic discriminant analysis as an aid to interpretive reporting of clinical laboratory tests. J.A.M.A. 248:2342–2345,1982a.
Ryback, R. S., Eckardt, M. J., Felsher, B., and Rawlings, R. R.: Biochemical and hematologic correlates of alcoholism and liver disease. J.A.M.A. 248:2261–2265, 1982b.
Salaspuro, M.: Conventional and coming laboratory markers of alcoholism and heavy drinking. Alcoholism: Clin. Exp. Res. 10:5S–12S, 1986.
Sanchez-Craig, M., and Annis, H. M.: Ganuna-glutamyl trans-peptidase and high-density lipoproteins cholesterol in male problem drinkers: Advantages of a composite index for pre-dicting alcohol consumption. Alcoholism: Clin. Exp. Res. 5: 540–544, 1981.
Sane, T., Nikkila, E. A., Taskinen, M. R., Valimaki, M., and Ylikahri, R.: Accelerated turnover of very low density lipo-protein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol. Atherosclerosis 53:185–193, 1984.
Schellenberg, F., and Weill, J.: Serum desialotransferrin in the detection of alcohol abuse. Alcohol Alcoholism (Suppl. 1): 625–629, 1987a.
Schellenberg, E., and Weill, J.: Serum desialotransferrin in the detection of alcohol abuse. Definition of a Tf index. Drug Alcohol Depend. 19:181–191, 1987b.
Schmidt, E., Schmidt, W., and Otto, P.: Isoenzymes of malic dehydrogenase, glutamic oxaloacetic transaminase and lactic dehydrogenase in serum in diseases of the liver. Clin. Chim. Acta. 15:283–289, 1967a.
Schmidt, E., Schmidt, F. W., and Mohr, J.: An improved simple chromatographic method for separating the isoenzymes of malic dehydrogenase and glutamic oxaloacetic transaminase. Clin. Chim. Acta. 15:337–342, 1967b.
Schneider, J., Liesenfeld, A., Mordasini, R., Schubotz, R., Zofel, P., Kubel, F., Vandre-Plozzitzka, C., and Kaffarnik, H.: Lipoprotein fractions, lipoprotein lipase and hepatic tri-glyceride lipase during short-term and long-term uptake of ethanol in healthy subjects. Atherosclerosis 57:281–291, 1985.
Selzer, M. L.: The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. Am. J. Psychiatry 127 :1653–1658, 1971.
Shaper, A. G., Pocock, S. J., Ashby, D., Walker, M., and Whitehead, T. P.: Biochemical and haematological response to alcohol intake. Ann. Clin. Biochem. 22:50–61, 1985.
Shaw, S., and Lieber, C. S.: Plasma amino acid abnormalities in the alcoholic. Respective role of alcohol, nutrition, and liver injury. Gastroenterology 74:677–682, 1978.
Shaw, S., and Lieber, C. S.: Mechanism of increased gamma glutamyl transpeptidase after chronic alcohol consumption. Hepatic microsomal induction rather than dietary imbalance. Subst. Alcohol Actions Misuse 1:423–428, 1980a.
Shaw, S., and Lieber, C. S.: Increased hepatic production of alpha-amino-n-butyric acid after chronic alcohol consumption in rats and baboons. Gastroenterology 78:108–113, 1980b.
Shaw, S., and Lieber, C. S.: Plasma amino acids in the alcoholic: Nutritional aspects. Alcoholism: Clin. Exp. Res. 7:22–27, 1983.
Shaw, S., Stimmel, B., and Lieber, C. S.: Plasma alpha-amino-n-butyric acid to leucine ratio: An empirical biochemical marker of alcoholism. Science 194:1057–1058, 1976.
Shaw, S., Lue, S. L., and Lieber, C. S.: Biochemical tests for the detection of alcoholism: Comparison of plasma alpha-amino-n-butyric acid with other available tests. Alcoholism: Clin. Exp. Res. 2:3–7, 1978.
Shaw, S., Worner, T. M., Borysow, M. F., Schmitz, R. E., and Lieber, C. S.: Detection of alcoholism relapse: Comparative diagnostic value of MCV, GGTP, and AANB. Alcoholism: Clin. Exp. Res. 3:297–301, 1979.
Sjoquist, B., Borg, S., and Kvande, H.: Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication. Subst. Alcohol Actions Misuse 2:63–72, 1981a.
Sjoquist, B., Borg, S., and Kvande, H.: Salsolinol and methylated salsolinol in urine and cerebrospinal fluid from healthy volun-teers. Subst. Alcohol Actions Misuse 2:73–77, 1981b.
Skinner, H. A., Holt, S., Schuller, R., Roy, J., and Israel, Y.: Identification of alcohol abuse using laboratory tests and a history of trauma. Ann. Intern. Med. 101:847–851, 1984.
Skude, G., and Wadstein, J.: Amylase, hepatic enzymes and bilirubin in serum of chronic alcoholics. Acta Med. Scand. 201:53–58, 1977.
Sobell, M. B., Sobell, L. C., and Vander Spek, R.: Relationships among clinical judgment, self-report, and breath-analysis measures of intoxication in alcoholics. J. Consult. Clin. Psychol. 47:204–206, 1979.
Sorrell, M. E, and’Iitma, D. J.: Selective impairment of glycopro-tein metabolism by ethanol and acetaldehyde in rat liver slices. Gastroenterology 75:200–205, 1978.
Sorrell, M. F, and Alma, D. J.: The functional implications of acetaldehyde binding to cell constituents. Ann. N.Y. Acad. Sci. 492:50–62, 1987.
Sorrell, M. F., Nauss, J. M., Donohue, T. M., and Lima, D. J.: Effects of chronic ethanol administration on hepatic glyco-protein secretion in the rat. Gastroenterology 84:580–586, 1983.
Sox, H. C.: Probability theory in the use of diagnostic tests. An introduction to critical study of the literature. Ann. Intern. Med. 104:60–66, 1986.
Spickard, A.: Alcoholism: The missed diagnosis. South. Med. J. 79:1489–1492, 1986.
Spik, G., Bayard, B., Fournet, B., Strecker, G., Bouquelet, S., and Montreuil, J.: Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett. 50:296–299, 1975.
Stamm, D., Hansert, E., and Feuerlein, W.: Detection and exclu-sion of alcoholism in men on the basis of clinical laboratory findings. J. Clin. Chem. Clin. Biochem. 22 :79–96, 1984.
Stevens, V. J., Fantl, W. J., Newman, C. B., Sims, R. V., Cerami, A., and Peterson, C. M.: Acetaldehyde adducts with hemo-globin. J. Clin. Invest. 67 :361–369, 1981.
Stibler, H., and Borg, S.: Evidence of a reduced sialic acid content in serum transferrin in male alcoholics. Alcoholism: Clin. Exp. Res. 5:545–549, 1981.
Stibler, H., and Borg, S.: Carbohydrate composition of serum transferrin in alcoholic patients. Alcoholism: Clin. Exp. Res. 10 :61–64, 1986.
Stibler, H., and Hultcrantz, R.: Carbohydrate-deficient transferrin serum in patients with liver diseases. Alcoholism: Clin. Exp. Res. 11 :468–473, 1987.
Stibler, H., Allgulander, C., Borg, S., and Kjellin, K. G.: Abnor-mal microheterogeneity of transferrin in serum and cerebro-spinal fluid in alcoholism. Acta Med. Scand. 204:49–56, 1978.
Stibler, H., Borg, S., and Allgulander, C.: Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption. Acta Med. Scand. 206:275–281, 1979.
Stibler, H., Sydow, O., and Borg, S.: Quantitative estimation of abnormal microheterogeneity of serum transferrin in alco-holics. Pharmacol. Biochem. Behay.13(Suppl.1) :47–51,1980.
Stibler, H., Borg, S., and Joustra, M.: Micro anion exchange chromatography of carbohydrate-deficient transferrin in se-rum in relation to alcohol consumption (Swedish Patent 8400587–5). Alcoholism: Clin. Exp. Res. 10:535–544, 1986.
Stockham, T. L., and Blanke, R. V.: Investigation of an acetalde-hyde—hemoglobin adduct in alcoholics. Alcoholism: Clin. Exp. Res. 12:748–754, 1988.
Storey, E. L., Mack, U., Powell, L. W., and Halliday, J. W.: Use of chromatofocusing to detect a transferrin variant in serum of alcoholic subjects. Clin. Chem. 31 :1543–1545, 1985.
Storey, E. L., Anderson, G. J., Mack, U., Powell, L. W., and Halliday, J. W.: Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet 1 : 1292–1294,1987.
Sullivan, J. L., Stanfield, C. N., Schanberg, S., and Cavenar, J.: Platelet monoamine oxidase and serum dopamine-ß-hydrox-ylase activity in chronic alcoholics. Arch. Gen. Psychiatry 35:1209–1212, 1978.
Sullivan, J. L., Cavenar, J. O., Maltbie, A. A., Lister, P., and Zung, W. W.K.: Familial biochemical and clinical correlates of alcoholics with low platelet monoamine oxidase activity. Biol. Psychiatry 14:385–394, 1979.
Swendseid, M. E., Yamada, C., Vinyard, E., Figueroa, W. G., and Drenick, E. J.: Plasma amino acid levels in subjects fed isonitrogenous diets containing different proportions of fat and carbohydrate.. Am. J. Clin. Nutr. 20 :52–55, 1967.
Swendseid, M. E., Yamada, C., Vinyard, E., and Figueroa, W. G.: Plasma amino acid levels in young subjects receiving diets containing 14 or 3.5 g nitrogen per day. Am. J. Clin. Nutr. 21 : 1381–1383,1968.
Swenson, W. M., and Morse, R. M.: The use of a Self-Administered Alcoholism Screening Test (SAAST) in a medi-cal center. Mayo Clin. Proc. 50 :204–208, 1975.
Tabakoff, B., Hoffman, P L., Lee, J. M., Saito, T., Willard, B., and De Leon-Jones, F: Differences in platelet enzyme activ-ity between alcoholics and nonalcoholics. N. Engl. J. Med. 318 :134–139, 1988.
Takahashi, S., Tani, N., and Yamane, H.: Monoamine oxidase activity in blood platelets in alcoholism. Folia Psychiatr. Neurol. Jpn. 30 :455–462, 1976.
Takase, S., Takada, A., Tsutsumi, M., and Matsuda, Y.: Bio-chemical markers of chronic alcoholism. Alcohol 2 :405–410, 1985.
Taskinen, M. R., Valimaki, M., Nikkila, E. A., Kuusi, T., Eheholm, C., and Ylikahri, R.: High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism 31 :1168–1174, 1982.
Taskinen, M. R., Valimaki, M., Nikkila, E. A., Kuusi, T., and Ylikahri, R.: Sequence of alcohol-induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans. Metabolism 34 :112–119, 1985.
Tàskinen, M. R., Nikkila, E. A., Valimaki, M., Sane, T., Kuusi, T., Kesaniemi, Y. A., and Ylikahri, R.: Alcohol-induced changes in serum lipoproteins and in their metabolism. Am. Heart J. 113 :458–464, 1987.
Tate, S. S., and Meister, A.: y-Glutamyl transpeptidase: Catalytic, structural and functional aspects. Mol. Cell. Biochem. 39 : 357–368, 1981.
Tateossian, S., Peynet, J. G., Legrand, A. G., Collet, B., Rossignol, I.A., Delattre, J. J., and Rousselet, F.J.: Variations in HDL and VLDL levels chronic alcoholics. Influence of the degree of liver damage and of withdrawal of alcohol. Clin. Chim. Acta 148 :211–219, 1985.
Teschke, R., Brand, A., and Strohmeyer, G.: Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption. Biochem. Biophys. Res. Com-mun. 75 :718–724, 1977.
Thornton, J., Symes, C., and Heaton, K.: Moderate alcohol intake reduces bile cholesterol saturation and raises HDL choles—terol. Lancet 2 :819–821, 1983.
Tonnesen, H., Hejberg, L., Frobenius, S., and Andersen, J. R.: Erythrocyte mean cell volume—correlation to drinking pat-tern in heavy alcoholics. Acta Med. Scand. 219:515–518, 1986.
Towel, J., Garthwaite, T., and Wang, R.: Erythrocyte aldehyde dehydrogenase and disulfiram-like side effects of hypo-glycemics and antianginals. Alcoholism: Clin. Exp. Res. 9 : 438–442,1985.
Towell, J. F., Barboriak, J. J., Townsend, W. F., Kalbfleisch, J. H., and Wang, R. I. H.: Erythrocyte aldehyde dehydrogenase: Assay of a potential biochemical marker of alcohol abuse. Clin. Chem. 32 :734–738, 1986.
Tsuboi, K. K., Thompson, D. J., Rush, E. M., and Schwartz, H. C.: Acetaldehyde-dependent changes in hemoglobin and ox-ygen affinity of human erythrocytes. Hemoglobin 5 :241–250, 1981.
Tsuji, M.: Measurement of platelet monoamine oxidase using three different substrates in patients with alcoholism and schizophrenia. Folia Psychiatr. Neurol. Jpn. 39 :521–530, 1985.
Titrpeinen, U.: Liquid-chromatographic determination of dolichols in urine. Clin. Chem. 32:2026–2029, 1986.
Tityns, A. J., and Pequignot, G.: Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int. J. Epidemiol. 13 :53–57, 1984.
Unger, K. W, and Johnson, D.: Red blood cell mean corpuscular volume: A potential indicator of alcohol usage in a working population. Am. J. Med. Sci. 267 :281–289, 1974.
Valimaki, M., Nikkila, E. A., Taskinen, M. R., and Ylikahri, R.: Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake. Atherosclerosis 59 :147–153, 1986.
Van Waes, L., and Lieber, C. S.: Glutamate dehydrogenase: A reliable marker of liver cell necrosis in the alcoholic. Br. Med. J. 2 :1508–1510, 1977.
Vesterberg, O., Petren, S., and Schmidt, D.: Increased concentra-tions of a transferrin variant after alcohol abuse. Clin. Chim. Acta 141 :33–39, 1984.
von Knorring, A. L., Bohman, M., von Knorring, L., and Oreland, L.: Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr. Scand. 72 :51–58, 1985.
Wadstein, J., and Skude, G.: Changes in amylase, hepatic en-zymes and bilirubin serum upon initiation of alcohol absti-nence. Acta Med. Scand. 205 :313–316, 1979a.
Wadstein, J., and Skude, G.: Serum ethanol, hepatic enzymes and length of debauch in chronic alcoholics. Acta Med. Scand. 205:317–318, 1979b.
Waechter, C. J., and Lennarz, W. is The role of polyprenol-linked sugars in glycoprotein synthesis. Annu. Rev. Biochem. 45 :95–110, 1976.
Walters, G. D., Jeffrey, T. B., Kruzich, D. J, Greene, R. L., and Haskin, J. J.: Racial variations on the MacAndrew Alcohol-ism Scale of the MMPI. J. Consult. Clin. Psychol. 51:947–948,1983.
Watson, C. G., Tilleskjor, C., Hoodecheck-Schow, E. A., Pucel, J., and Jacobs, L.: Do alcoholics give valid self-reports? J. Stud. Alcohol 45:344–348, 1984.
Whitfield, J. B., Pounder, R. E., Neale, G., and Moss, D. W.: Serum y-glutamyl transpeptidase activity in liver disease. Gut 13:702–708, 1972.
Whitfield, J. B., Moss, D. W., Neale, G., Orme, M., and Breckenridge, A.: Changes in plasma y-glutamyl transpep-tidase activity associated with alterations in drug metabolism in man. Br. Med. J. 1:316–318, 1973.
Whitfield, J. B., Allen, J. K., Adena, M., Gallagher, H. G., and Hensley, W. J.: A multivariate assessment of alcohol con-sumption. Int. J. Epidemiol. 10:281–288, 1981.
Wiberg, A., Gottfries, C. G., and Oreland, L.: Low platelet monoamine oxidase activity in human alcoholics. Med. Biol. 55:181–186, 1977.
Williams, A. L. B., and Hoofnagle, J. H.: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 95:734–739, 1988.
Wong, T. K., and Lennarz, W. J.: The site of biosynthesis and intracellular deposition of dolichol in rat liver. J. Biol. Chem. 257:6619–6624, 1982.
Worner, T. M., and Lieber, C. S.: Plasma glutamate dehydroge-nase: Clinical application in patients with alcoholic liver disease. Alcoholism: Clin. Exp. Res. 4:431–434, 1980.
Wu, A., Chanarin, I., and Levi, A. J.: Macrocytosis of chronic alcoholism. Lancet 1:829–830, 1974.
Wu, A., Chanarin, I., Slavin, G., and Levi, A. J.: Folate defi-ciency in the alcoholic—its relationship to clinical and hema-tological abnormalities, liver disease and folate stores. Br. J. Haematol. 29:469–478, 1975.
Wu, A., Slavin, G., and Levi, A. J.: Elevated serum gamma-glutamyl-transferase (transpeptidase) and histological liver damage in alcoholism. Am. J. Gastroenterol. 65:318–323, 1976.
Xin, Y., Lasker, J. M., Rosman, A. S., and Lieber, C. S.: Iso-electric focusing/Western blotting: A novel and practical method for quantitation of carbohydrate-deficient transferrin in alcoholics. Alcoholism: Clin. Exp. Res. 15:814–821, 1991.
Xin, Y., Rosman, A. S., Lasker, J. M., and Lieber, C. S.: Measure-ment of carbohydrate-deficient transferrin by isoelectric focusing/Western blotting and by micro anion-exchange chromatography/radioimmunoassay: Comparison of diagnos-tic accuracy. Alcohol Alcohol. (in press), 1992.
Yamada, S., Wilson, J. S., and Lieber, C. S.: The effects of ethanol and diet on hepatic and serum y-glutamyltranspeptidase ac-tivities in rats. J. Nutr. 115 :1285–1290, 1985a.
Yamada, S., Mak, K. M., and Lieber, C. S.: Chronic ethanol consumption alters rat liver plasma membranes and potenti-ates release of alkaline phosphatase. Gastroenterology 88: 1799–1806, 1985b.
Yamada, K., Yokohama, H., Abe, S., Katayama, K., and Sato, T.: High-performance liquid chromatographic method for the determination of dolichols in tissues and plasma. Anal. Bio-chem. 150:26–31, 1985c.
Yudkoff, M., Blazer-Yost, B., Cohn, R., and Segal, S.: On the clinical significance of the plasma a-amino-n-butyric acid: leucine ratio. Am. J. Clin. Nutr. 32:282–285, 1979.
Zimmerman, H. J., and West, M.: Serum enzyme levels in the diagnosis of hepatic disease. Am. J. Gastroenterol. 40:387–402,1963.
Zorzano, A., Ruiz del Arbol, L., and Herrera, E.: Effect of liver disorders on ethanol elimination and alcohol and aldehyde dehydrogenase activities in liver and erythrocytes. Clin. Sci. 76:51–57, 1989.
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rosman, A.S., Lieber, C.S. (1992). Biological Markers of Alcoholism. In: Medical and Nutritional Complications of Alcoholism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3320-7_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3320-7_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6462-7
Online ISBN: 978-1-4615-3320-7
eBook Packages: Springer Book Archive